De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMID 24456026)

Published in Am J Transplant on January 23, 2014


S K Asrani1, R H Wiesner, J F Trotter, G Klintmalm, E Katz, E Maller, J Roberts, N Kneteman, L Teperman, J J Fung, J M Millis

Author Affiliations

1: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN; William J. von Liebig Transplant Center, Mayo Clinic, Rochester, MN; Annette C and Harold-Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX.

Articles citing this

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59

Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol (2015) 0.82

What's new in clinical solid organ transplantation by 2013. World J Transplant (2014) 0.81

Review on immunosuppression in liver transplantation. World J Hepatol (2015) 0.79

Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement. Transplantation (2016) 0.79

The role of everolimus in liver transplantation. Clin Exp Gastroenterol (2014) 0.79

Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice. Am J Transplant (2016) 0.77

Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses. PLoS One (2016) 0.77

The benefit of sirolimus maintenance immunosuppression and rabbit antithymocyte globulin induction in liver transplant recipients that develop acute kidney injury in the early postoperative period. J Transplant (2015) 0.75

Anticoagulant therapy with fondaparinux in a liver transplant patient with thrombosis and liver fibrosis: a case report. Clin Case Rep (2017) 0.75

Immunological aspects of liver cell transplantation. World J Transplant (2016) 0.75

Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study. World J Gastroenterol (2016) 0.75

Sirolimus and mTOR inhibitors in liver transplantation: the wheel has come full circle. Am J Transplant (2014) 0.75

Articles by these authors

A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis (2000) 6.71

Cloning and expression of the tyrosinase gene from Streptomyces antibioticus in Streptomyces lividans. J Gen Microbiol (1983) 6.44

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

National estimates of blood lead levels: United States, 1976-1980: association with selected demographic and socioeconomic factors. N Engl J Med (1982) 5.64

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell (1996) 5.10

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Jack Kevorkian: a medical hero. BMJ (1996) 4.87

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Liver from bone marrow in humans. Hepatology (2000) 4.10

Do sick newborn infants benefit from participation in a randomized clinical trial? J Pediatr (1999) 3.98

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Rifampicin: a specific inhibitor of vaccinia virus assembly. Nature (1969) 3.74

Predicting child abuse: signs of bonding failure in the maternity hospital. Br Med J (1977) 3.70

Publishing research supported by the tobacco industry. BMJ (1996) 3.65

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology (1980) 3.57

Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin. Proc Natl Acad Sci U S A (1970) 3.50

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Prevalence of myopia in the United States. Arch Ophthalmol (1983) 3.00

Induction of avian tumor viruses in normal cells by physical and chemical carcinogens. Virology (1971) 3.00

Interobserver agreement and disagreement in continuous recording exemplified by measurement of behavior state. Am J Ment Retard (1997) 2.95

alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Natl Acad Sci U S A (2001) 2.92

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

The peptide antibiotics of Bacillus: chemistry, biogenesis, and possible functions. Bacteriol Rev (1977) 2.89

Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84

Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex (2007) 2.83

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

Successful liver transplantation from crossmatch-positive donors. Transplant Proc (1981) 2.80

Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA (1999) 2.78

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75


Joint teleconsultations (virtual outreach) versus standard outpatient appointments for patients referred by their general practitioner for a specialist opinion: a randomised trial. Lancet (2002) 2.62

Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62

Transplantation of liver grafts from living donors into adults--too much, too soon. N Engl J Med (2001) 2.61

Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc (1990) 2.60

Revised "joint statement" clarifies relationships between midwives and physician collaborators. J Midwifery Womens Health (2001) 2.60

Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation (1990) 2.59

Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc (1991) 2.59

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57

Debate over US Gulf war syndrome continues. BMJ (1994) 2.54

Specialists in the United States: what lessons? BMJ (1995) 2.53

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

Pregnancy after liver transplantation under tacrolimus. Transplantation (1997) 2.50

Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

Nanoparticle arrays on surfaces for electronic, optical, and sensor applications. Chemphyschem (2000) 2.42

Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ (2012) 2.39

General practice observed. Child abuse and general practice. Br Med J (1976) 2.39

Prioritization and organ distribution for liver transplantation. JAMA (1994) 2.38

Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med (1997) 2.38

Current concepts. Primary sclerosing cholangitis. N Engl J Med (1984) 2.35

The antibody crossmatch in liver transplantation. Surgery (1986) 2.33

Body mass index: a comparison between self-reported and measured height and weight. J Public Health Med (1998) 2.32

The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32

Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31

Does contingent reinforcement strengthen operant behavior? J Exp Anal Behav (1987) 2.31

The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens (2014) 2.29

Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. Transplant Proc (1991) 2.28

Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl (2000) 2.27

Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25

Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24

Resurgence of sleeping sickness in Tambura County, Sudan. Am J Trop Med Hyg (1999) 2.24

Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant (2006) 2.22

Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22

Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation (1992) 2.20

Three years clinical experience with intestinal transplantation. J Am Coll Surg (1994) 2.20

Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology (1999) 2.19

Specialized nucleoprotein structures at the origin of replication of bacteriophage lambda: complexes with lambda O protein and with lambda O, lambda P, and Escherichia coli DnaB proteins. Proc Natl Acad Sci U S A (1985) 2.19

The nucleotide sequence of the tyrosinase gene from Streptomyces antibioticus and characterization of the gene product. Gene (1985) 2.19

Effects of alcohol intoxication on the perceived consequences of risk taking. Exp Clin Psychopharmacol (1997) 2.17

Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J Biol Chem (1990) 2.16

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis (1996) 2.12

Vaccinia virus structural polypeptide derived from a high-molecular-weight precursor: formation and integration into virus particles. J Virol (1970) 2.11

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology (1994) 2.10

One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10

Non-response bias in a lifestyle survey. J Public Health Med (1997) 2.10

A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09

The side effects of FK 506 in humans. Transplant Proc (1990) 2.08

HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin. Lancet (1986) 2.08

Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1991) 2.06

Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet (1995) 2.04

Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant (2010) 2.04

Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg (1998) 1.99

Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest (1990) 1.99

Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. Transplantation (1991) 1.95

Where next for prophylaxis against pre-eclampsia? Br J Obstet Gynaecol (1996) 1.95